Skip to main content
Erschienen in: Archives of Dermatological Research 9/2019

05.08.2019 | Original Paper

Association between sphingosine-1-phosphate-induced signal transduction via mitogen-activated protein kinase pathways and keloid formation

verfasst von: Seung Hyo Jung, Yu Kwan Song, Hong Chung, Hyun Myung Ko, Sung Hoon Lee, Dong In Jo, Bokyung Kim, Dong Hee Lee, Soon Heum Kim

Erschienen in: Archives of Dermatological Research | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

We conducted this experimental study to analyze the relationship between sphingosine-1-phosphate (S1P)-induced mitogen-activated protein (MAP) kinase pathways and keloid formation. We collected samples of the normal tissue and the keloid tissue from 10 normal healthy individuals and 12 patients with keloid scars, respectively. Then, we compared the level of sphingosine-1-phosphate receptor (S1PR1/S1PR2) mRNA/protein expression between the normal tissue and the keloid tissue. Moreover, we also compared the level of S1PR protein expression, that of S1P-induced COL1A1 (collagen Type I, α-1 chain) expression, that of S1P-induced JNK/ERK phosphorylation, that of S1P-induced COL1A1 expression following the treatment with 30 μM PD98059 (ERK inhibitor) or 30 μM SP600125 (JNK inhibitor) and that of S1P-induced COL1A1 expression following the treatment with W146 (S1PR1 inhibitor) or JTE013 (S1PR2 inhibitor) between the normal fibroblasts and the keloid fibroblasts. We found that the level of S1PR1/S1PR2 mRNA/protein expression was significantly higher in the keloid tissue as compared with the normal tissue. Our results also showed that the level of S1P-induced COL1A1 expression and that of S1P-induced JNK/ERK phosphorylation were significantly higher in the keloid fibroblasts as compared with the normal ones (P < 0.05). Furthermore, there were significant decreases in the level of S1P-induced COL1A1 expression when the keloid fibroblasts were treated with 30 μM SP600125 or 30 μM PD98059 and that of S1P-induced COL1A1 expression when the treated with 100 nM W146 or 100 nM JTE013 (P < 0.05). Our results indicate that S1P-induced signal transduction is associated with increased collagen synthesis via S1PR-mediated signaling pathways in the keloid tissue.
Literatur
1.
Zurück zum Zitat Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117:286–300CrossRef Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117:286–300CrossRef
2.
Zurück zum Zitat An D, Na C, Bielawski J, Hannun YA, Kasper DL (2011) Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine. Proc Natl Acad Sci USA 108(Suppl 1):4666–4671CrossRef An D, Na C, Bielawski J, Hannun YA, Kasper DL (2011) Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine. Proc Natl Acad Sci USA 108(Suppl 1):4666–4671CrossRef
3.
Zurück zum Zitat Arciniegas E, Carrillo LM, Rojas H, Ramírez R, Chopite M (2019) Galectin-1 and galectin-3 and their potential binding partners in the dermal thickening of keloid tissues. Am J Dermatopathol 41:193–204CrossRef Arciniegas E, Carrillo LM, Rojas H, Ramírez R, Chopite M (2019) Galectin-1 and galectin-3 and their potential binding partners in the dermal thickening of keloid tissues. Am J Dermatopathol 41:193–204CrossRef
4.
Zurück zum Zitat Brew K, Nagase H (2016) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803:55–71CrossRef Brew K, Nagase H (2016) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803:55–71CrossRef
5.
Zurück zum Zitat Chang NS (2000) TGF-beta-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated IkappaBalpha degradation and NF-kappaB nuclear translocation in L929 fibroblasts. Biochem Biophys Res Commun 267:194–200CrossRef Chang NS (2000) TGF-beta-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated IkappaBalpha degradation and NF-kappaB nuclear translocation in L929 fibroblasts. Biochem Biophys Res Commun 267:194–200CrossRef
6.
Zurück zum Zitat Dohi T, Miyake K, Aoki M et al (2015) Tissue inhibitor of metalloproteinase-2 suppresses collagen synthesis in cultured keloid fibroblasts. Plast Reconstr Surg Glob Open 3:e520CrossRef Dohi T, Miyake K, Aoki M et al (2015) Tissue inhibitor of metalloproteinase-2 suppresses collagen synthesis in cultured keloid fibroblasts. Plast Reconstr Surg Glob Open 3:e520CrossRef
7.
Zurück zum Zitat Gamard CJ, Dbaibo GS, Liu B, Obeid LM, Hannun YA (1997) Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappaB. J Biol Chem 272:16474–16481CrossRef Gamard CJ, Dbaibo GS, Liu B, Obeid LM, Hannun YA (1997) Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappaB. J Biol Chem 272:16474–16481CrossRef
8.
Zurück zum Zitat Gauglitz GG (2013) Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol 6:103–114CrossRef Gauglitz GG (2013) Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol 6:103–114CrossRef
9.
Zurück zum Zitat Gill SE, Parks WC (2008) Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 40:1334–1347CrossRef Gill SE, Parks WC (2008) Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 40:1334–1347CrossRef
10.
Zurück zum Zitat Hait NC, Maiti A (2017) The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer. Mediators Inflamm 2017:4806541CrossRef Hait NC, Maiti A (2017) The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer. Mediators Inflamm 2017:4806541CrossRef
11.
Zurück zum Zitat He S, Liu X, Yang Y et al (2010) Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br J Dermatol 162:538–546CrossRef He S, Liu X, Yang Y et al (2010) Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br J Dermatol 162:538–546CrossRef
12.
Zurück zum Zitat Heffernan-Stroud LA, Obeid LM (2013) Sphingosine kinase 1 in cancer. Adv Cancer Res 117:201–235CrossRef Heffernan-Stroud LA, Obeid LM (2013) Sphingosine kinase 1 in cancer. Adv Cancer Res 117:201–235CrossRef
13.
Zurück zum Zitat Hu ZC, Tang B, Guo D et al (2014) Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar. Clin Exp Dermatol 39:822–828CrossRef Hu ZC, Tang B, Guo D et al (2014) Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar. Clin Exp Dermatol 39:822–828CrossRef
14.
Zurück zum Zitat Huang C, Murphy GF, Akaishi S, Ogawa R (2013) Keloids and hypertrophic scars: update and future directions. Plast Reconstr Surg Glob Open 1:e25CrossRef Huang C, Murphy GF, Akaishi S, Ogawa R (2013) Keloids and hypertrophic scars: update and future directions. Plast Reconstr Surg Glob Open 1:e25CrossRef
15.
Zurück zum Zitat Ishihara H, Yoshimoto H, Fujioka M et al (2000) Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. J Invest Dermatol 115:1065–1071CrossRef Ishihara H, Yoshimoto H, Fujioka M et al (2000) Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. J Invest Dermatol 115:1065–1071CrossRef
16.
Zurück zum Zitat Kim S, Kim Y, Lee Y, Chung JH (2008) Ceramide accelerates ultraviolet-induced MMP-1 expression through JAK1/STAT-1 pathway in cultured human dermal fibroblasts. J Lipid Res 49:2571–2581CrossRef Kim S, Kim Y, Lee Y, Chung JH (2008) Ceramide accelerates ultraviolet-induced MMP-1 expression through JAK1/STAT-1 pathway in cultured human dermal fibroblasts. J Lipid Res 49:2571–2581CrossRef
17.
Zurück zum Zitat Kim SH, Jung SH, Chung H et al (2014) Annexin A2 participates in human skin keloid formation by inhibiting fibroblast proliferation. Arch Dermatol Res 306:347–357CrossRef Kim SH, Jung SH, Chung H et al (2014) Annexin A2 participates in human skin keloid formation by inhibiting fibroblast proliferation. Arch Dermatol Res 306:347–357CrossRef
18.
Zurück zum Zitat Kitatani K, Idkowiak-Baldys J, Hannun YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20:1010–1018CrossRef Kitatani K, Idkowiak-Baldys J, Hannun YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20:1010–1018CrossRef
19.
Zurück zum Zitat Kye KC, Chae EK, Piao YJ et al (2004) Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts. J Invest Dermatol 122:1365–1371CrossRef Kye KC, Chae EK, Piao YJ et al (2004) Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts. J Invest Dermatol 122:1365–1371CrossRef
21.
Zurück zum Zitat Lee JH, Kim SE, Lee AY (2008) Effects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol 47:183–186CrossRef Lee JH, Kim SE, Lee AY (2008) Effects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol 47:183–186CrossRef
22.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408CrossRef Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408CrossRef
23.
Zurück zum Zitat Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585:193–201CrossRef Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585:193–201CrossRef
24.
Zurück zum Zitat Ponnusamy S, Meyers-Needham M, Senkal CE et al (2010) Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol 6:1603–1624CrossRef Ponnusamy S, Meyers-Needham M, Senkal CE et al (2010) Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol 6:1603–1624CrossRef
25.
Zurück zum Zitat Ryu JM, Baek YB, Shin MS et al (2014) Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways. Stem Cell Res 12:69–85CrossRef Ryu JM, Baek YB, Shin MS et al (2014) Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways. Stem Cell Res 12:69–85CrossRef
26.
Zurück zum Zitat Saray Y, Güleç AT (2005) Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Dermatol 44:777–784CrossRef Saray Y, Güleç AT (2005) Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Dermatol 44:777–784CrossRef
27.
Zurück zum Zitat Sayah DN, Soo C, Shaw WW et al (1999) Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 87:209–216CrossRef Sayah DN, Soo C, Shaw WW et al (1999) Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 87:209–216CrossRef
28.
Zurück zum Zitat Spiegel S, Merrill AH Jr (1996) Sphingolipid metabolism and cell growth regulation. FASEB J 10:1388–1397CrossRef Spiegel S, Merrill AH Jr (1996) Sphingolipid metabolism and cell growth regulation. FASEB J 10:1388–1397CrossRef
29.
Zurück zum Zitat Strub GM, Maceyka M, Hait NC, Milstien S, Spiegel S (2010) Extracellular and intracellular actions of sphingosine-1-phosphate. Adv Exp Med Biol 688:141–155CrossRef Strub GM, Maceyka M, Hait NC, Milstien S, Spiegel S (2010) Extracellular and intracellular actions of sphingosine-1-phosphate. Adv Exp Med Biol 688:141–155CrossRef
30.
Zurück zum Zitat Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA, Bayat A (2011) Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol 164:83–96CrossRef Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA, Bayat A (2011) Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol 164:83–96CrossRef
31.
Zurück zum Zitat Tawada C, Kanoh H, Nakamura M et al (2014) Interferon-γ decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis. J Invest Dermatol 134:712–718CrossRef Tawada C, Kanoh H, Nakamura M et al (2014) Interferon-γ decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis. J Invest Dermatol 134:712–718CrossRef
32.
Zurück zum Zitat van den Broek LJ, Limandjaja GC, Niessen FB, Gibbs S (2014) Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective. Exp Dermatol 23:382–386CrossRef van den Broek LJ, Limandjaja GC, Niessen FB, Gibbs S (2014) Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective. Exp Dermatol 23:382–386CrossRef
33.
Zurück zum Zitat Wang XQ, Liu YK, Qing C, Lu SL (2009) A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids. Ann Plast Surg 63:688–692CrossRef Wang XQ, Liu YK, Qing C, Lu SL (2009) A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids. Ann Plast Surg 63:688–692CrossRef
34.
Zurück zum Zitat Watters RJ, Wang HG, Sung SS, Loughran TP, Liu X (2011) Targeting sphingosine-1-phosphate receptors in cancer. Anticancer Agents Med Chem 11:810–817CrossRef Watters RJ, Wang HG, Sung SS, Loughran TP, Liu X (2011) Targeting sphingosine-1-phosphate receptors in cancer. Anticancer Agents Med Chem 11:810–817CrossRef
35.
Zurück zum Zitat Whitmarsh AJ (2007) Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. Biochim Biophys Acta 1773:1285–1298CrossRef Whitmarsh AJ (2007) Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. Biochim Biophys Acta 1773:1285–1298CrossRef
36.
Zurück zum Zitat Wu J, Spiegel S, Sturgill TW (1995) Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism. J Biol Chem 270:11484–11488CrossRef Wu J, Spiegel S, Sturgill TW (1995) Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism. J Biol Chem 270:11484–11488CrossRef
37.
Zurück zum Zitat Xiu L, Chang N, Yang L et al (2015) Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors. Am J Pathol 185:387–398CrossRef Xiu L, Chang N, Yang L et al (2015) Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors. Am J Pathol 185:387–398CrossRef
38.
Zurück zum Zitat Yeap YY, Ng IH, Badrian B et al (2010) c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18. Biochem J 430:345–354CrossRef Yeap YY, Ng IH, Badrian B et al (2010) c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18. Biochem J 430:345–354CrossRef
39.
Zurück zum Zitat Zhang GY, Gao WY, Li X et al (2009) Effect of camptothecin on collagen synthesis in fibroblasts from patients with keloid. Ann Plast Surg 63:94–99CrossRef Zhang GY, Gao WY, Li X et al (2009) Effect of camptothecin on collagen synthesis in fibroblasts from patients with keloid. Ann Plast Surg 63:94–99CrossRef
Metadaten
Titel
Association between sphingosine-1-phosphate-induced signal transduction via mitogen-activated protein kinase pathways and keloid formation
verfasst von
Seung Hyo Jung
Yu Kwan Song
Hong Chung
Hyun Myung Ko
Sung Hoon Lee
Dong In Jo
Bokyung Kim
Dong Hee Lee
Soon Heum Kim
Publikationsdatum
05.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 9/2019
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-019-01961-6

Weitere Artikel der Ausgabe 9/2019

Archives of Dermatological Research 9/2019 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.